abstract |
A farnesoid X receptor (FXR) agonist for use in the treatment of hepatitis B virus (HBV) infection in a subject in need thereof, selected from the group consisting of the compound identified by CAS REGISTRATION NUMBER 1192171 -69-9, GW4064 formula ** (See formula) ** and 6-ethyl-5-chenodeoxycholic acid ** (See formula) ** (6ECDCA) formula |